Paul Field
Net worth: 64 $ as of 2026-08-30
Net worth: 64 $ as of 2026-08-30
Paul Field was the founder of Bio-Link Partners Ltd., founded in 2005, where the title held was Executive Chairman from 2005 to 2014.
Current jobs include Independent Director at 60 Degrees Pharmaceuticals, Inc. since 2023 and Independent Non-Executive Director at Invion Ltd. starting in 2026.
Former job includes Director at Australian Institute of Co. Directors.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-07-01 | 59 ( 0% ) | 64 $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| 60 DEGREES PHARMACEUTICALS, INC. | Director/Board Member | 2023-07-11 |
| INVION LIMITED | Director/Board Member | 2026-08-18 |
| Companies | Position | End |
|---|---|---|
Bio-Link Partners Ltd.
Bio-Link Partners Ltd. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology business development company | Founder | 2013-12-31 |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Bio-Link Partners Ltd.
Bio-Link Partners Ltd. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology business development company | Commercial Services |
Invion Ltd.
Invion Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Health Technology |
60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for infectious diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions